Systemic Mastocytosis Types and Treatment

Mast cell disease classified by indolent, aggressive, and mast cell leukemia subtypes.

Written by: Saygı Hospital Health Guide Editorial Board

Last updated: June 9, 2026

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Systemic Mastocytosis Types and Treatment?

Systemic mastocytosis is a rare mast cell disease that causes accumulation of clonal mast cells primarily in the bone marrow and various organs. The KIT D816V mutation is identified in most cases.

The WHO classification includes indolent, smoldering, aggressive systemic mastocytosis, mast cell leukemia, and systemic mastocytosis with associated hematologic neoplasm subtypes.

Treatment is determined by type; symptomatic H1/H2 blockade, cromoglycate, and lifestyle modification in indolent forms, midostaurin and avapritinib in aggressive forms, and stem cell transplantation in selected cases are used.

Symptoms

Flushing and pruritus

Anaphylaxis and urticaria pigmentosa

Abdominal pain and diarrhea

Weight loss and hepatosplenomegaly

Osteoporosis and pathological fracture

Neuropsychiatric symptoms

Bone marrow failure

Risk Factors

KIT D816V mutation

Family history of mastocytosis

Elevated tryptase level

History of urticaria pigmentosa

History of anaphylaxis

Coexisting hematologic disease

Form detected at advanced age

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

Frequent recurrent flushing and anaphylaxis
High baseline tryptase (>20)
Unexplained osteoporosis
Hepatosplenomegaly and cytopenias
KIT D816V positivity
Progressive systemic symptoms

Treatment Methods

H1/H2 antihistamine combination

Oral cromoglycate

Midostaurin in aggressive forms

Avapritinib targeted therapy

Stem cell transplantation in selected cases

Osteoporosis and bone health management

Trigger avoidance education

Epinephrine pen and anaphylaxis plan

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book Appointment Contact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.